Tetraphase Pharmaceuticals Announces Inducement Grants

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
44
Tetraphase Pharmaceuticals Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

WATERTOWN, Mass., July 12, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH ), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, today announced that Tetraphase's Compensation Committee of the Board of Directors approved, pursuant to NASDAQ Listing Rule 5635(c)(4), the grant of inducement equity awards in the form of stock options to four new employees to purchase an aggregate of 60,000 shares of Tetraphase's common stock. The options were granted as an inducement equity awards outside Tetraphase's 2013 Stock Incentive Plan and were made as an inducement material to four new employee’s acceptance of employment with Tetraphase.

The stock options have exercise prices equal to the closing price of Tetraphase's common stock on July 13, 2018. The options have a ten-year term and vest over four years, with 25% of the original number of shares vesting on July 13, 2019, and an additional 6.25% of the original number of shares vesting at the end of each successive quarter thereafter, subject to the respective new employee’s continued service with Tetraphase through the applicable vesting dates.

About Tetraphase Pharmaceuticals, Inc. Tetraphase is a biopharmaceutical company using its proprietary chemistry technology to create novel antibiotics for serious and life-threatening bacterial infections, including those caused by many of the MDR bacteria highlighted as urgent public health threats by the Centers for Disease Control and Prevention. The Company has created more than 3,000 novel tetracycline compounds using its proprietary technology platform. Tetraphase's pipeline includes three antibiotic clinical candidates: eravacycline, which has completed phase 3 clinical trials and is under review for potential approval in complicated intra-abdominal infections by the U.S. Food and Drug Administration and the European Medicines Agency, and TP-271 and TP-6076, which are in phase 1 clinical trials. Please visit www.tphase.com for more company information.

Forward-Looking Statements Any statements in this press release about our future expectations, plans and prospects, including statements regarding our strategy, future operations, prospects, plans and objectives, and other statements containing the words "anticipates," "believes," "expects," "plans," "will" and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: whether the Company's regulatory submission will receive approval from the United States Food and Drug Administration or equivalent foreign regulatory agencies; whether, if any clinical candidate, including eravacycline, obtains approval, it will be successfully distributed and marketed; and other factors discussed in the "Risk Factors" section of our quarterly report on Form 10-Q for the period ended March 31, 2018, filed with the Securities and Exchange Commission on May 3, 2018. In addition, the forward-looking statements included in this press release represent our views as of July 12, 2018. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we specifically disclaim any obligation to do so.

Media and Investor Contact: Jennifer Viera jviera@tphase.com   617-600-7040

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ZTO's Pricing Muscle Shows Up in Third-Quarter Results

Updated Category News Views 116

Ten billion parcels can hide plenty of ugly economics, but ZTO's third quarter does not look like a volume-at-any-cost stunt. The company moved 10.241 billion parcels, up 7.0% from a year earlier, and says that outpaced the industry by 4.1 percentage points. More importantly, revenue climbed 21.0% to RMB14.36 billion while adjusted net income reached RMB2.57 billion. That...

Continue Reading
Benicia's Bold Move to Streamline Permitting Pays Off

Updated Category News Views 127

Award-Winning Innovation from Benicia Benicia, California, shoots ahead of the pack by scooping up a highly coveted Helen Putnam Award for Excellence. Why? They chopped down bureaucracy like a lumberjack with a new ax by ushering in a digital revolution for their permitting process. Make no mistake, folks, this ain’t just a pat on the back—it's a blueprint for cities...

Continue Reading
SanMar’s Lott Tops Promo Products Power 50 Again in 2026

Updated Category News Views 43

Branded hoodies and logo tumblers rarely make Wall Street’s pulse race, but the numbers behind them deserve a hard look. Jeremy Lott, president and CEO of SanMar, was named the most influential leader in the U.S. promotional-products business for the second consecutive year, taking No. 1 in the 2026 Counselor Power 50 ranking. Awards can be fluff. A repeat win beside...

Continue Reading
PSEG Declares $0.67 Fourth-Quarter 2026 Cash Dividend

Updated Category News Views 64

A 67-cent utility dividend rarely sets the tape on fire, and that is precisely the point. Public Service Enterprise Group declared a regular fourth-quarter 2026 common-stock dividend of $0.67 per share, payable on or before December 31 to shareholders of record on December 10. For owners of NYSE:PEG, this is the sort of announcement that belongs in the “steady as she...

Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks

Updated Category News Views 186

Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...

Continue Reading
Charter’s $1.5 Billion Tender Tests Debt Discipline

Updated Category News Views 176

Debt cleanup arrives with a hard ceiling Eight far-dated bond issues just got a very specific invitation from Charter Communications: hand them over for cash, but do not expect the company to write a blank check. Charter set final pricing on November 17 for tender offers covering up to $1.5 billion in aggregate consideration, excluding accrued interest and deal expenses....

Continue Reading
EUBG Faces Tough Third Quarter Amid Challenges

Updated Category News Views 226

What's Happening with EUBG? Entrepreneur Universe Bright Group, better known in the markets as EUBG, is navigating some choppy waters if their recent financial numbers are anything to go by. You'd think companies boasting a digital-focused strategy would be printing money in today's tech-driven world, but EUBG's third quarter of 2026 has a different story to tell. The...

Continue Reading
Wonder Create: Democratizing Restaurant Creation

Updated Category News Views 57

Breaking Down Barriers in the Restaurant Industry It's been a long time since someone truly shook up the restaurant scene like this. Wonder Create is stepping in to turn anyone with a wild food idea into a bonafide restaurateur. We're not talking about the ol' franchising route here. We're diving straight into democratizing the culinary world. You seen something this bold...

Continue Reading
Texas Community Bancshares Adds a Special Dividend

Updated Category News Views 109

Nine cents is the whole message—for the moment Texas Community Bancshares has put a little extra cash on the table, declaring a regular quarterly dividend of $0.06 per common share and a special cash dividend of $0.03 per share. Together, holders get $0.09 per share, payable on or about December 15, 2026, provided they are shareholders of record when business closes on...

Continue Reading
Toledo Crosswalk Death Lawsuit Raises Hard Questions

Updated Category News Views 193

A painted crosswalk is supposed to mean something, and that is the grim center of the lawsuit filed over Judy Tanner’s death in Toledo. Tanner, 20, was walking home from work on September 10, 2026, when she was struck and killed while crossing the street. Her estate is now suing, alleging that the 31-year-old driver failed to yield as Tanner legally used the crosswalk....

Continue Reading

Top 5 Most Recently Viewed Articles

Riyadh Gears Up for UNIDO 2025: A Step Towards Sustainable Industry

Updated Category News Views 180

Riyadh Gears Up for UNIDO 2025 Riyadh is on the verge of an exciting global event as it prepares to host the 21st Session of the United Nations Industrial Development Organization (UNIDO) General Conference. This significant summit is scheduled to happen at the King Abdulaziz International Conference Centre, where leaders from various sectors will gather to discuss the...

Continue Reading
Deer Park Road Strategizes for Growth Amid CRE Market Changes

Updated Category News Views 205

Deer Park Road Strategies in a Changing CRE Landscape Deer Park Road Management Company, LP, a notable $2.8 billion alternative asset management firm, is honing in on emerging prospects within the challenging environment of the Commercial Mortgage-Backed Securities (CMBS) market. The firm’s extensive expertise enables them to consistently identify potential value during...

Continue Reading
iRobot Corporation Faces Legal Challenges Amid Financial Struggles

Updated Category News Views 141

Legal Investigations into iRobot Corporation Investors are currently facing uncertainties surrounding iRobot Corporation as it faces legal scrutiny. The well-respected law firm Faruqi & Faruqi, LLP has initiated investigations regarding potential legal claims on behalf of investors who suffered significant losses. Who to Contact James (Josh) Wilson, a partner at Faruqi &...

Continue Reading
Dr. Andrea Fuyuko Honda Recognized for Medical Innovation Excellence

Updated Category News Views 385

Dr. Andrea Fuyuko Honda's Recent Recognition Dr. Andrea Fuyuko Honda has been prominently recognized as a Pinnacle Professional Member within an elite circle of excellence. This accolade reflects her significant contributions to the field as a Leading Medical Communications Expert and Innovator. With a career spanning over fifteen years, Dr. Honda has demonstrated...

Continue Reading
Centene Corporation Faces Securities Fraud Legal Action

Updated Category News Views 206

Centene Corporation Faces New Lawsuit Over Securities Fraud Investors of Centene Corporation, known by the ticker symbol CNC, have found themselves at the center of a securities fraud lawsuit. Recently, a leading law firm announced the initiation of legal action against Centene Corporation and some of its senior executives. This lawsuit stems from alleged violations of...

Continue Reading